Mauro Moscucci, MD

The Relative Renal Safety of Iodixanol and Low-Osmolar Contrast Media in Patients Undergoing PCI (Full Title Below)
10/06/2010
The Relative Renal Safety of Iodixanol and Low-Osmolar Contrast Media in Patients Undergoing Percutaneous Coronary Intervention Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
The Relative Renal Safety of Iodixanol and Low-Osmolar Contrast Media in Patients Undergoing Percutaneous Coronary Intervention Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
The Relative Renal Safety of...
10/06/2010
Journal of Invasive Cardiology
A Regional, Multi-Hospital Consortium for Quality Improvement in Coronary Angioplasty
06/19/2008
How did the consortium come into existence? We’ve always been interested in clinical outcomes of coronary intervention, and how to improve those outcomes. In 1997, it occurred to us that single institutions don’t have the ability to collect...
How did the consortium come into existence? We’ve always been interested in clinical outcomes of coronary intervention, and how to improve those outcomes. In 1997, it occurred to us that single institutions don’t have the ability to collect...
How did the consortium come into...
06/19/2008
Cath Lab Digest
Feature
A Regional, Multi-Hospital Consortium for Quality Improvement in Coronary Angioplasty
06/19/2008
How did the consortium come into existence? We’ve always been interested in clinical outcomes of coronary intervention, and how to improve those outcomes. In 1997, it occurred to us that single institutions don’t have the ability to collect...
How did the consortium come into existence? We’ve always been interested in clinical outcomes of coronary intervention, and how to improve those outcomes. In 1997, it occurred to us that single institutions don’t have the ability to collect...
How did the consortium come into...
06/19/2008
Cath Lab Digest
Feature
Frequency and Costs of Ischemic and Bleeding Complications After Percutaneous Coronary Interventions: Rationale for New Antithro
08/01/2008
Recent advances in catheter technology and antithrombotic therapy have led to a continuous improvement in outcomes of percutaneous coronary intervention (PCI). These improved outcomes have been associated with broadening of the indications...
Recent advances in catheter technology and antithrombotic therapy have led to a continuous improvement in outcomes of percutaneous coronary intervention (PCI). These improved outcomes have been associated with broadening of the indications...
Recent advances in catheter...
08/01/2008
Journal of Invasive Cardiology
Feature
Frequency and Costs of Ischemic and Bleeding Complications After Percutaneous Coronary Interventions: Rationale for New Antithro
08/01/2008
Continued from previous page Bleeding complications in practice. Demographics and definitions. As mentioned previously, data from multi- and single-center registries of PCI report much higher bleeding complication rates than those seen in...
Continued from previous page Bleeding complications in practice. Demographics and definitions. As mentioned previously, data from multi- and single-center registries of PCI report much higher bleeding complication rates than those seen in...
Continued from previous...
08/01/2008
Journal of Invasive Cardiology

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use